Topics

Photo

Expert Interview: Michael Quirmbach, CordenPharma

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has uncovered problems that have been smoldering beneath the surface and need to be addressed. That supply chains are vulnerable to disruption when major development, production and transportation hubs are blocked or shut down has become painfully obvious.

Photo

Accelerated Drug Discovery

In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.

Photo

The Importance of Innovation for Future Success

Innovative strength has been a cornerstone of Bachem’s business success since the founding nearly 50 years ago. Günther Loidl, Chief Technology Officer for Bachem Holding, talks about a new innovation management system that will further heighten the importance of innovation in the future.

Photo

Evolving an Entrepreneurial Ecosystem

We are in the midst of a start-up revolution. The growth of innovation-driven start-up activity is profound and global in scope, and it is a driving force of change even in mature industries such as the chem­ical and pharmaceutical sector.

Photo

High Standards and Innovation Experience

As a production and innovation partner, JRS Contract Manufacturing supports those involved in special projects in product development, series start-ups, implementation of marketing-relevant product features, process optimization or capacity expansion.

Photo

Upcycling of Post-Consumer PLA Waste

Designed for their performance and durability, synthetic plastics have become indispensable as “materials of every-day use”. However, their characteristic long life span and indiscriminate disposal have led to an acute problem of plastic pollution. In order to address this issue, the European Union is not only trying to adopt a circular system to reuse, repair and recycle plastics (circular economy) but it also aims to produce plastics out of renewable resources (biobased plastics).

Photo

Circular Economy

The chemical industry is on the threshold of a new era – the age of circularity. We asked industry experts to share their opinions on this transformational topic.

Photo

Reshaping Adhesion - and the Industry

Hybrid assemblies, joints of dissimilar materials, are everywhere - in our smartphones, cars, TVs, dishwashers, in planes and so on. However, in modern products we increasingly rely on plastics, which are intrinsically hard to bond to other types of material — and by using industrial glue for the bonding the parts cannot be recy­cled easily. Solving this monumental challenge inspired the foun­dation of the Danish start-up company RadiSurf five years ago.

Photo

Contributing to the Circular Economy

Cellugy was founded two years ago by a diverse team of young academics and professionals from Spain, Indonesia, Albania, and Denmark. Working together at Aarhus University in Denmark, the idea of developing a material based on nanocellulose as an alternative to plastic barrier coatings arose and grew into a start-up and a first product. Co-founders Isabel Alvarez-Martos and Deby Fapyane talk about their motivation and vision.

Photo

Creating the AI-Powered Future of Chemistry

Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.

Photo

High Level Chemical Logistics

As an independent system of uniform third party assessments, SQAS — Safety and Quality Assessment System —was initiated to evaluate the performance of logistics service providers and chemical distributors.

1626 more Topics

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.